ZWITTERIONIC LIPID NANOPARTICLE COMPOSITIONS, AND METHODS OF USE

    公开(公告)号:US20240307309A1

    公开(公告)日:2024-09-19

    申请号:US18268472

    申请日:2021-12-21

    CPC classification number: A61K9/145 A61K31/7105

    Abstract: A lipid nanoparticle composition comprising: (i) at least one zwitterionic polymer-containing lipid in which a lipid moiety is covalently attached to a zwitterionic polymer; (ii) at least one non-cationic lipid selected from charged and uncharged lipids, but not attached to a polymer; (iii) at least one cationic or ionizable lipid; and (iv) at least one therapeutic substance, and optionally (v) cholesterol or derivative thereof. Also described herein are methods of delivering a therapeutic substance to a subject, the method comprising administering to the subject a lipid nanoparticle composition described above.

    METHODS FOR ENHANCED NUCLEIC ACID DELIVERY

    公开(公告)号:US20250064741A1

    公开(公告)日:2025-02-27

    申请号:US18722792

    申请日:2022-12-20

    Abstract: A method for delivery of a nucleic acid. comprising administering a lipid nanoparticle composition loaded with the nucleic acid to a subject in which monocytes and/or macrophages have been depleted. thereby delivering the nucleic acid into the subject, the method may more particularly be practiced according to the following steps: a) depleting monocytes and/or macrophages in a subject: and b) administering a lipid nanoparticle composition loaded with the nucleic acid to the subject, thereby delivering the nucleic acid into the subject.

Patent Agency Ranking